
Alpha Cognition Reports Q2 and H1 2024 Financial Results and Corporate Update
Alpha Cognition Inc. (NASDAQ: ACOG) (CSE: ACOG), a biopharmaceutical company focused on developing therapies for neurodegenerative diseases, has released its financial results for the second quarter and six months ending September 30, 2024, along with a corporate update. Key Updates:…












